MX2008004981A - Composiciones para el tratamiento de enfermedades de los ojos. - Google Patents

Composiciones para el tratamiento de enfermedades de los ojos.

Info

Publication number
MX2008004981A
MX2008004981A MX2008004981A MX2008004981A MX2008004981A MX 2008004981 A MX2008004981 A MX 2008004981A MX 2008004981 A MX2008004981 A MX 2008004981A MX 2008004981 A MX2008004981 A MX 2008004981A MX 2008004981 A MX2008004981 A MX 2008004981A
Authority
MX
Mexico
Prior art keywords
composition according
lycopene
vitamin
composition
lutein
Prior art date
Application number
MX2008004981A
Other languages
English (en)
Spanish (es)
Inventor
Yoav Sharoni
Joseph Levy
Yoram Sela
Zohar Nir
Original Assignee
Lycored Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lycored Ltd filed Critical Lycored Ltd
Publication of MX2008004981A publication Critical patent/MX2008004981A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
MX2008004981A 2005-10-16 2006-10-05 Composiciones para el tratamiento de enfermedades de los ojos. MX2008004981A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL17145205 2005-10-16
PCT/IL2006/001168 WO2007046083A2 (en) 2005-10-16 2006-10-05 Compositions for treatment of eye diseases

Publications (1)

Publication Number Publication Date
MX2008004981A true MX2008004981A (es) 2008-10-17

Family

ID=37962894

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008004981A MX2008004981A (es) 2005-10-16 2006-10-05 Composiciones para el tratamiento de enfermedades de los ojos.

Country Status (7)

Country Link
EP (1) EP1937240A2 (ru)
JP (1) JP2009515821A (ru)
AU (1) AU2006305546A1 (ru)
IL (1) IL190779A0 (ru)
MX (1) MX2008004981A (ru)
RU (1) RU2008119234A (ru)
WO (1) WO2007046083A2 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101254818B1 (ko) 2004-11-09 2013-04-15 쿠프론 인코포레이티드 피부 보호 방법 및 물질
WO2008108825A2 (en) * 2006-10-10 2008-09-12 Burnham Institute For Medical Research Neuroprotective compositions and methods
DE202007012373U1 (de) * 2007-09-04 2009-01-08 Omnivision Gmbh Nahrungsergänzungsmittel, Beutel mit einem Nahrungsergänzungsmittel sowie Verwendung eines Nahrungsergänzungsmittels
WO2010060729A1 (en) * 2008-11-03 2010-06-03 Giuliani S.P.A. Therapeutic, dietary, or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3, and compositions containing these compounds
AU2010205367B2 (en) * 2009-01-19 2015-06-18 Lycored Ltd Synergistic combinations of carotenoids and polyphenols
WO2011076869A1 (en) * 2009-12-22 2011-06-30 Aakerlund Hans-Erik Isolated green plant material
JP2011256118A (ja) * 2010-06-07 2011-12-22 Kao Corp Ｉｌ−８及びｇｍ−ｃｓｆ発現抑制剤
KR20140008299A (ko) * 2010-10-04 2014-01-21 쿠프론 인코포레이티드 화장용 피부 관리 조성물
WO2013009378A1 (en) * 2011-07-13 2013-01-17 University Of Georgia Research Foundation, Inc. Use of xanthophyll carotenoids to improve visual performance and neural efficiency
CN103798808A (zh) * 2012-11-15 2014-05-21 中国科学院大连化学物理研究所 一种营养素配方及在缓解视疲劳的食品或药物中的应用
EP3179988A4 (en) * 2014-08-11 2018-11-14 Board of Supervisors of Lousiana State University Delivery of bioactive, nanoencapsulated antioxidants
US20170354704A1 (en) * 2014-11-25 2017-12-14 Lycored Ltd. Biologically-active tomato composition having reduced amount of lycopene
JP7105532B2 (ja) * 2017-05-10 2022-07-25 ロート製薬株式会社 後眼部疾患の予防、改善、又は治療用組成物
US20200113846A1 (en) * 2017-07-25 2020-04-16 Tathagata DUTTA A topical ocular suspension of antioxidants
WO2019087189A1 (en) * 2017-11-01 2019-05-09 Lycored Ltd. A method for improving ocular blood flow
US11696593B2 (en) 2018-08-24 2023-07-11 Bioscience Formulators, LLC Astaxanthin nutritional compositions and uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye

Also Published As

Publication number Publication date
IL190779A0 (en) 2009-02-11
WO2007046083A2 (en) 2007-04-26
WO2007046083A3 (en) 2011-05-19
RU2008119234A (ru) 2009-11-27
JP2009515821A (ja) 2009-04-16
AU2006305546A1 (en) 2007-04-26
EP1937240A2 (en) 2008-07-02

Similar Documents

Publication Publication Date Title
MX2008004981A (es) Composiciones para el tratamiento de enfermedades de los ojos.
EP1383399B1 (en) Nutritional supplement to treat macular degeneration
EP1471898B1 (en) Lutein/zeaxanthin for glare protection
US7887847B2 (en) Nutritional supplement for treatment of ocular diseases
US20090035369A1 (en) Composition and Methods for Treating and Preventing Age-Related Macular Degeneration
US20110021974A1 (en) Retinitis pigmentosa treatment and prophalaxis
ES2732744T3 (es) Composición para la salud ocular
EP2646010B1 (en) Folic acid - ramipril combination: cellprotective, neuroprotective and retinoprotective ophtalmologic compositions
Tanito Reported evidence of vitamin E protection against cataract and glaucoma
KR20160140859A (ko) 당뇨성 안질환에 대한 친지질성 영양소의 효과
CN102178925A (zh) 新型视力保护剂叶黄素眼用制剂
JP2002017295A (ja) 眼疾患改善作用及び眼の機能維持作用を有する健康補助食品
KR20180118951A (ko) 안구 질환 예방 또는 개선용 건강기능식품 조성물
JP5893438B2 (ja) 網膜症の予防又は改善剤
JP7090336B2 (ja) Ｎａｄ関連代謝産物の利用
FI3897595T3 (en) NUTRITIONAL OPHTHALMIC COMPOSITION FOR THE TREATMENT OF RETINA DISEASES WITH A NEOVASCULAR COMPONENT
Gaby Nutritional therapies for ocular disorders: part three
US20220152140A1 (en) Composition of desmodium and trivalent chromium, and ocular use
RU2806096C2 (ru) Нутрицевтическая офтальмологическая композиция для лечения патологий сетчатки с неоваскулярным компонентом
EP2531184A1 (en) Docosahexaenoic acid ethyl esters and/or its derivatives for prevention and/or treatment of age-related macular degeneration
WO2021055419A1 (en) Compositions for improving eye health and methods of making and using thereof
WO2015165507A1 (en) Treatment of eye diseases using omega 3 fatty acids and aa/epa blood ratio
CN116115592A (zh) 维生素a或其衍生物在制备治疗青光眼疾病药物中的应用
Pawaskar et al. Dietary supplements and drugs available in India along with the mechanism of action and clinical trial data for the medical management of age related macular degeneration (AMD)
FARER How to Maintain or Even Improve Your Vision as You Age

Legal Events

Date Code Title Description
FA Abandonment or withdrawal